Browsed by
Tag: controlled

Health economic evaluation of a randomized controlled trial (EMBLA study), an internet-based treatment for provoked vulvodynia
Health economic evaluation of a randomized controlled trial (EMBLA study), an internet-based treatment for provoked vulvodynia

Health economic evaluation of a randomized controlled trial (EMBLA study), an internet-based treatment for provoked vulvodynia

Design This overall health financial analysis has a health care company point of view and is based on information from the EMBLA study, a multicenter randomized analyze that investigated the results of a 6-7 days guided world-wide-web intervention for provoked vulvodynia21. The analyze was accepted by the Ethical Regional Board in Uppsala, Sweden (registration numbers 2015/031 and 2020–07,179), and registered at clinicaltrials.gov (protocol ID EMBLA, ID NCT02809612, 22/06/2016). All experiments ended up done in accordance with the Declaration of Helsinki…

Read More Read More

ScriptCheckWA a ‘game changer’ in battle to curb addiction, abuse of controlled medicines
ScriptCheckWA a ‘game changer’ in battle to curb addiction, abuse of controlled medicines

ScriptCheckWA a ‘game changer’ in battle to curb addiction, abuse of controlled medicines

A new electronic checking system is remaining rolled out to medical professionals and pharmacists across WA to help overcome “medical professional buying” for prescription medication. Key details: Medical doctor procuring for prescription medications is a expanding trouble A plan intended to fight it will focus on drugs these as morphine, oxycodone and methadone The technique is built to improve health practitioner-pharmacy communication Medical professional searching is when individuals consult a range of diverse medical doctors to attain prescriptions for drugs such as morphine,…

Read More Read More

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Summary Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. We aimed to establish whether the addition of molnupiravir to usual care reduced hospital admissions and deaths associated with COVID-19 in this population. Methods PANORAMIC was a UK-based, national, multicentre, open-label, multigroup, prospective, platform adaptive randomised controlled trial. Eligible participants were aged 50 years or older—or…

Read More Read More